Cargando…
BMS-754807 is cytotoxic to non-small cell lung cancer cells and enhances the effects of platinum chemotherapeutics in the human lung cancer cell line A549
BACKGROUND: Despite advances in targeted therapy for lung cancer, survival for patients remains poor and lung cancer remains the leading cause of cancer-related deaths worldwide. The type I insulin-like growth factor receptor (IGF-IR) has emerged as a potential target for lung cancer treatment, howe...
Autores principales: | Franks, S. Elizabeth, Jones, Robert A., Briah, Ritesh, Murray, Payton, Moorehead, Roger A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772483/ https://www.ncbi.nlm.nih.gov/pubmed/26928578 http://dx.doi.org/10.1186/s13104-016-1919-4 |
Ejemplares similares
-
Unique roles of Akt1 and Akt2 in IGF-IR mediated lung tumorigenesis
por: Franks, S. Elizabeth, et al.
Publicado: (2015) -
Differential Effects of IGF-1R Small Molecule Tyrosine Kinase Inhibitors BMS-754807 and OSI-906 on Human Cancer Cell Lines
por: Fuentes-Baile, María, et al.
Publicado: (2020) -
Antioxidant Antagonises Chemotherapeutic Drug Effect in Lung Cancer Cell Line A549
por: Rajendran, Swetha, et al.
Publicado: (2020) -
A High-Throughput In Vitro Drug Screen in a Genetically Engineered Mouse Model of Diffuse Intrinsic Pontine Glioma Identifies BMS-754807 as a Promising Therapeutic Agent
por: Halvorson, Kyle G., et al.
Publicado: (2015) -
Ferri–Liposomes: Preformulation and Selective Cytotoxicity against A549 Lung Cancer Cells
por: de Souza, Marina Guedes Fonseca, et al.
Publicado: (2021)